|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:1419
© 2006 The American Association for Thoracic Surgery
Letter to the Editor |
Ann Arbor, Mich
Cox and associates
1
recently presented in vitro testing results on the 3F Aortic Bioprosthesis. Unfortunately, Cox and colleagues chose not to give authorship to any of the engineers who performed this work, nor even give them the courtesy of an acknowledgement. Due to the lack of input from these engineers, of whom I am one, the article contains several technical and interpretive errors that should be corrected. They are as follows:
These corrections are not intended to be petty or esoteric. As the clinical use of the 3F aortic valve continues to grow, it is important to have accurate literature reports of how the valve has been tested, as well as sound technical analyses of its performance features. Rather than relying on ill-conceived theories of "tubular" geometry or "form follows function," the valve's excellent performance can be attributed to more straightforward design features (ie, the leaflet design, the small, unobstructive sewing ring, the lack of rigid supports structures, and the mechanical durability of pericardium). An intellectually and scientifically rigorous paper with a description of these features and how they translate to the observed performance would have been much more useful.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. L. Cox and R.C. Quijano Tubular heart valves J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 845 - 846. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |